Dr. Muruganandan Shanmugam

Biomedical Scientist with a Doctor of Veterinary Medicine and a Doctor of Philosophy in a Drug Discovery Research Program. Research experience in diverse areas - Stem Cells & Regenerative Medicine, Molecular Biology, Gene Therapy, and Experimental Therapeutics. An accomplished researcher with more than fifteen years of experience in pre-clinical drug development, and exploration and discovery of novel therapeutic targets to treat tissue degeneration associated with diabetes, cardiac & renal damage, immunological injury, cancer, osteoporosis, and inflammation. Identified new targets and therapeutic strategies using molecular and cell-based systems and as well as animal models for all these diseases. Proven leadership in both academic and industrial environments. Experience working in a fast-paced and collaborative environment. Expert in developing and managing SOPs, QC documents, and Tech transfer documents. Published more than 30 scientific articles, which have received more than 4000 citations. Prepared or participated in submitting grant applications to several agencies, including CIHR, NSHRF, NSERC, and Canadian Cancer Society. Previously, I worked as Research Associate & Lab Manager at Harvard University, where I investigated the therapeutic potential of targeting abnormal signaling pathways that disrupt the normal stem cell development to benefit patients suffering from skeletal tissue damage.